Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples